Masimo Corporation (MASI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Masimo Corporation (MASI) has a cash flow conversion efficiency ratio of 0.084x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($60.50 Million) by net assets ($721.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Masimo Corporation for the company's overall valuation and market capitalisation.
Masimo Corporation - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Masimo Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Masimo Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Masimo Corporation ranked by their cash flow conversion efficiency. Explore MASI cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FirstCash Inc
NASDAQ:FCFS
|
0.076x |
|
Pandora A/S
CO:PNDORA
|
0.010x |
|
Puig Brands SA
MC:PUIG
|
0.241x |
|
thyssenkrupp AG
XETRA:TKA
|
-0.120x |
|
Chart Industries Inc
NYSE:GTLS
|
0.035x |
|
Bentley Systems Inc
NASDAQ:BSY
|
0.158x |
|
Repligen Corporation
NASDAQ:RGEN
|
0.016x |
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
-0.036x |
Annual Cash Flow Conversion Efficiency for Masimo Corporation (1998–2025)
The table below shows the annual cash flow conversion efficiency of Masimo Corporation from 1998 to 2025. View MASI stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $721.20 Million | $217.80 Million | 0.302x | +61.75% |
| 2024-12-31 | $1.05 Billion | $196.40 Million | 0.187x | +170.80% |
| 2023-12-31 | $1.36 Billion | $94.10 Million | 0.069x | +213.99% |
| 2022-12-31 | $1.34 Billion | $29.40 Million | 0.022x | -87.14% |
| 2021-12-31 | $1.55 Billion | $264.60 Million | 0.171x | +13.82% |
| 2020-12-31 | $1.41 Billion | $211.10 Million | 0.150x | -20.98% |
| 2019-12-31 | $1.17 Billion | $221.64 Million | 0.190x | -23.22% |
| 2018-12-31 | $969.07 Million | $239.53 Million | 0.247x | +207.98% |
| 2017-12-31 | $724.02 Million | $58.11 Million | 0.080x | -89.21% |
| 2016-12-31 | $560.24 Million | $416.84 Million | 0.744x | +79.62% |
| 2015-12-31 | $275.71 Million | $114.21 Million | 0.414x | +33.54% |
| 2014-12-31 | $307.74 Million | $95.46 Million | 0.310x | +86.40% |
| 2013-12-31 | $326.40 Million | $54.32 Million | 0.166x | -39.19% |
| 2012-12-31 | $275.67 Million | $75.43 Million | 0.274x | -3.08% |
| 2011-12-31 | $279.67 Million | $78.96 Million | 0.282x | +6.43% |
| 2010-12-31 | $230.04 Million | $61.02 Million | 0.265x | +63.07% |
| 2009-12-31 | $289.69 Million | $47.12 Million | 0.163x | -54.33% |
| 2008-12-31 | $219.50 Million | $78.18 Million | 0.356x | +85.44% |
| 2007-12-31 | $150.07 Million | $28.82 Million | 0.192x | -94.23% |
| 2006-12-31 | $56.96 Million | $189.63 Million | 3.329x | +7510.61% |
| 2005-12-31 | $-101.08 Million | $4.54 Million | -0.045x | +93.30% |
| 1999-12-31 | $19.10 Million | $-12.80 Million | -0.670x | -26.30% |
| 1998-12-31 | $14.70 Million | $-7.80 Million | -0.531x | -- |
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more